Showing results (171-180 of 234) with videos related to
Sort By:
Pageof 24
Plos One|January 12, 2013
Structural characterization of Pandoraea pnomenusa B-356 biphenyl dioxygenase reveals features of potent polychlorinated biphenyl-degrading enzymesChristopher L Colbert, Nathalie Y R Agar, Pravindra Kumar, et al.Bioconjugate Chemistry|July 22, 2011
Chemically programmed antibodies targeting multiple alpha(v) integrins and their effects on tumor-related functions in vitroRajib K Goswami, Krishna M Bajjuri, Jane S Forsyth, et al.ACS Medicinal Chemistry Letters|October 16, 2020
Brain Permeable Tafamidis Amide Analogs for Stabilizing TTR and Reducing APP CleavageAnjana Sinha, Jerry C Chang, Peng Xu, et al.Journal for Immunotherapy of Cancer|August 8, 2020
Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8<sup>+</sup> T cellsSandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, et al.Anesthesia and Analgesia|April 18, 2009
A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient settingTong J Gan, Ashish C Sinha, Anthony L Kovac, et al.Chemical Communications (Cambridge, England)|March 31, 2017
SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growthSaumya Roy, Jun Y Axup, Jane S Forsyth, et al.Nature Communications|August 19, 2021
Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breastVidya C Sinha, Amanda L Rinkenbaugh, Mingchu Xu, et al.Yearbook of Medical Informatics|October 13, 2010
Human factors for capacity building: lessons learned from the OpenMRS implementers networkC J Seebregts, B W Mamlin, P G Biondich, et al.Proceedings of the National Academy of Sciences of the United States of America|March 27, 2020
Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicitySandeep Kumar, Sunil Kumar Singh, Navin Viswakarma, et al.ACS Chemical Biology|December 11, 2023
Rational Development of a Small-Molecule Activator of CK1γ2 That Decreases C99 and Beta-Amyloid LevelsVictor Hugo Bustos, Yashoda Krishna Sunkari, Anjana Sinha, et al.Pageof 24